CD79A and COVID-19: Levels of antibodies against the acetylcholine receptor (IgA), α-synucleins (IgA), amyloid β peptide (IgA), D2 receptor (IgA), and myelin basic protein (IgA) were elevated in COVID-19 patients’ sera regardless of disease severity.